International Journal of Oncology

Article	Citations
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)	114
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)	89
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway	88
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer	83
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)	80
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells	71
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes	57
Identification and characterization of slow‑cycling cells in Ewing sarcoma	53
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer	51
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer	48
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)	48
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals	43
Role of miR‑181a‑5p in cancer (Review)	40
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma	38
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells	38
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)	36
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer	36
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression	35
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol	35
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)	35
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)	32
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)	32
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors	32
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential	31
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma	30

Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells	30
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin	30
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3	28
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A20	28
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression	27
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation	26
[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway	26
Application of cfDNA methylation in cancer prognostic assessment: Progress and challenges (Review)	24
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation	24
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)	24
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)	24
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer	24
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)	23
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer	23
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)	23
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization	23
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4	23
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway	23
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway	22
[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway	22
[Retracted] MicroRNA‑181a regulates epithelial‑mesenchymal transition by targeting PTEN in drug‑resistant lung adenocarcinoma cells	21
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells	21
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)	21
Role of miRNA‑122 in cancer (Review)	20
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)	20
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells	20
[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein	20
[Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1	20
Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells	20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma	20
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma	19
HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation	19
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)	19
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer	19
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway	19
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)	19
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy	19
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑1	19
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review	18
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer	18
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)	18
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review)	18
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells	18
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway	18
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)	18
Role of DCLK1 in oncogenic signaling (Review)	18
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway	18
[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways	18
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3	18
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)	18

Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality	17
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)	17
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion	17
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells	17
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells	17
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma	17
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)	17
[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma	17
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9	16
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)	16
Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein	16
CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)	16
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)	16
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells	15
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway	15
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer	15
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)	15
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer	15
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α	15
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome	15
MicroRNA in adenoid cystic carcinoma (Review)	15
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells	15
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia	14
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration	14
[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis	14
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis	14
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)	14
Establishment of patient‑derived lung tumorspheres and their response to internal irradiation by Auger electrons	14
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma	14
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)	14
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)	14
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer	14
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells	13
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling	13
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)	13
[Retracted] Expression and function of PIM kinases in osteosarcoma	13
m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling	13
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway	13
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma	13
Targeting drug resistance in glioblastoma (Review)	13
Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis	13
Circular RNAs in osteosarcoma: An update of recent studies (Review)	13
Roles of salt‑inducible kinases in cancer (Review)	13
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer	13
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase‑9	13
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)	13
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis	13
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)	13
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling	13
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer	12
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells	12
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation	12
Function of microRNA‑124 in the pathogenesis of cancer (Review)	12
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells	12
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)	12
ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells	12
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma	12
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia	12
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer	12
mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)	11
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts	11
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)	11
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H	11
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)	11
New insights into lipid metabolism and prostate cancer (Review)	11
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)	11
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance	11
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)	11
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model	11
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion	11
Role of microRNAs in glycolysis in gynecological tumors (Review)	11
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer	11
Tumor suppressive functions of WNT5A in rhabdomyosarcoma	11
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation	11
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits	11
P2Y2R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells	11
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)	11
[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells	11
[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway	10
[Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids	10

[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles	10
Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer	10
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine	10
Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway	10
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion	10
SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma	10
Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment	10
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells	10
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHR	10
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation	10
Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer	10
Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma	10
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)	10
Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review)	9
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway	9
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review)	9
[Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells	9
Adjusting for comorbidity in observational cancer studies: A systematic review to assess alignment between index and study	9
circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis	9
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway	9
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)	9
[Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT2	9
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)	9
Spine‑specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor‑positive breast cancer by activating glutamine‑dependent mTOR signaling	9
Molecular targets of primary cilia defects in cancer (Review)	9
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)	9
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway	9
S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)	9
[Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression	8
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer	8
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)	8
RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment (Review)	8
MicroRNA‑21: A potential therapeutic target in lung cancer (Review)	8
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)	8
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)	8
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells	8
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)	8
Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells	8
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer	8
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer	8
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer	8
Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer	8
WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15	8
Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9	8
Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors	8
[Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin‑like growth factor 2 imprinting	8
Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)	8
[Retracted] SRF‑miR‑29b‑MMP2 axis inhibits NSCLC invasion and metastasis	8
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway	8
Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER+ breast cancer cells	8
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)	8
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal	7
Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer	7
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer	7
Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)	7
DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells	7
Roles of m6A modification in oral cancer (Review)	7
N6‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression	7
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)	7
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)	7
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation	7
Targeting ferroptosis in Helicobacter pylori ‑associated gastric cancer development: From molecular mechanisms to application prospects (Review)	7
A perspective on the chemical structures and molecular mechanisms of curcumin and its derivatives and analogs in cancer treatment (Review)	7
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway	7
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)	7
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1low/negative non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy	7
N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer	7
Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer	7
A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2	6
Targeting neddylation as a novel approach to lung cancer treatment (Review)	6
Harnessing TP73‑targeted nintedanib: A novel strategy to halt triple‑negative breast cancer via p53‑PPARα/PI3K‑Akt pathway suppression	6
Eupalinolide A induces autophagy via the ROS/ERK signaling pathway in hepatocellular carcinoma cells in vitro and in vivo	6
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients	6
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA	6
Long non‑coding RNAs in multiple myeloma (Review)	6
Synergistic and toxicity‑reducing effects of acteoside as an adjuvant therapy of oxaliplatin against hepatocellular carcinoma	6
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)	6
Decoding the role of cancer stem cells in digestive tract tumors: Mechanisms and therapeutic implications (Review)	6
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth	6
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels	6
MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia	6
Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc	6
[Corrigendum] Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway	6
[Corrigendum] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer	6
DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions	6
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)	6
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)	6
Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7	6
[Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma	6
Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis	6
[Retracted] MicroRNA‑24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3	6
An emerging role of radiation‑induced exosomes in hepatocellular carcinoma progression and radioresistance (Review)	6
Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer	6
‘Reverse Warburg effect’ of cancer‑associated fibroblasts (Review)	6
Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review)	6